Dr Pascale POUKENS-RENWART Scientific Officer

Slides:



Advertisements
Similar presentations
1 Harmonisation of requirements: where we are Erik Waterdrinker, IFAH-Europe 2nd Veterinary Workshop on E-submission 4 Dec 2009, EMEA, London.
Advertisements

Dr. Raghuveer Pharma Consultants D R P C Quality. Perfection. Confidentiality. D R P C Quality. Perfection. Confidentiality. 1.
Certification of Substances Division,
Rule-Making Book II EU Administrative Procedures – The ReNEUAL Draft Model Rules 2014 Brussels, May th Herwig C.H. Hofmann University of Luxembourg.
BROMI Variations – An Industry Perspective
BROMI Variations Training Meeting 8th May 2008 Case Study Session BROMI VARIATIONS.
GMP Document and Record Retention
Relevance and effectiveness Regional Good Standardization Practice Course July, Bangkok, Thailand Good Standardization Practice 2012.
1 XXXXXXXXXXXXXXXXXXX, Malaysia, XXXXXX September, S.3.2 Impurities, Malaysia, 29 September 2011 Options for submitting API data to support.
1 Use and content of the RFP  Request for Proposals (RFP) is similar to bidding documents and include all information of the assignment, selection of.
Batch Reworking and Reprocessing
© 2005 Food Supplements Guidance Note Dr. Muireann Cullen Technical Executive
Sultan Ghani WHO Prequalification Programme of Priority Essential Medicines, October 2010, Abu Dhabi, U.A.E. Active Pharmaceutical Ingredient Master.
Quality control of raw materials In-process control
Sultan Ghani WHO Prequalification Programme of Priority Essential Medicines, October 2010, Abu Dhabi, U.A.E. Variations Maintenance of Prequalified.
Variations to Prequalified Medicines Rutendo Kuwana Workshop on WHO prequalification requirements for reproductive health medicines, Jakarta, October 2009.
Reference, Retention and Reserve Samples
Regulatory requirements on Medicine Stability Guidelines relevant for Stability testing Sultan Ghani.
Management of Change Control. Overview Changes – Good or bad? Forced or voluntary? The Importance of Change Control Major Changes to both legacy company.
PROACTIS: Supplier User Guide Contract Management.
Structure of Dossier of Medicinal Product- Q part
Post approval changes- Variations Mercy Acquaye. Presentation Outline Introduction to Guidance Classification of changes Approval of changes Definitions.
Changes in the project. Joint Technical Secretariat Seminar for Beneficiaries February 2012 Narva, Estonia.
World Health Organization
By: Carol Martineau, Acting Assistant Manager, Aircraft Maintenance Division, AFS-301 Date: June 7, 2015 Federal Aviation Administration ASA Conference.
1 Supplements and Other Changes to an Approved Application By: Richard J. Stec Jr., Ph.D. February 7, 2007.
Quality of Substances for Pharmaceutical Use: The EDQM Certification of Suitability to the European Pharmacopoeia Monographs (CEP) Dr. Susanne Keitel DIA.
PRODUCT TRANSFER.
Information on the Certification Procedure Dr P. Poukens-Renwart Certification of Substances Division, EDQM P.Poukens-Renwart, 05/09/09 ©2009 EDQM, Council.
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. THE PRACTICE OF REGULATORY INTELLIGENCE: CASE STUDIES OMICS 5 th International Pharmaceutical.
1 Impurities: Positions of the regulatory authorities (like FDA and EMA) worldwide Dr. Christian Zeine, Warsaw, Nov 18, 2014 Science for a safer world.
DMF Procedures and Communication between API, FP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
Monograph Development Process for the European Pharmacopoeia: How to participate in the work programme of the European Pharmacopoeia Dr Claude Coune Head.
1 TG Dekker – WHO, UkraineOctober 2005 Introduction to Dossier Requirements and Guidelines within the Prequalification Project (quality part) World Health.
Theo Dekker -- CPH -- Nov |2 | Meeting of WHO PQP with European manufacturers and EU holders of marketing authorisations WHO Prequalification of.
DOI Complaint Response Timeline Claims Services 2015 This timeline is applicable to DOI Inquiries/Complaints for all states where we do business. The dates.
© AL IPA/EDQM/IDMA Symposium 2007, All rights reserved The Ph. Eur. policy on impurities Dr Andrea Lodi Deputy Head, Laboratory Department, EDQM, Council.
Ivowen Ltd1 Ivowen Limited Preparation and Submission of a Traditional Herbal Medicinal Product Application.
IPA-EDQM Mumbai 11/2007 ©2007 EDQM, Council of Europe 1 Content of the application for a CEP Hélène BRUGUERA Deputy Head Certification of Substances Division.
International conference Quality of Active Pharmaceutical Ingredients Hyderabad, September 2009 API Inspections: the EDQM experience – 7 September.
API’s Registration Process supported by Apteka-95 Pharmaceutical Firm, Ltd. API’s Registration Process supported by Apteka-95 Pharmaceutical Firm, Ltd.
Thesis Defense and Submission 1 Spring  Register for Spring semester  Deadline to submit thesis to GPS: Friday, April 22 nd at NOON  Deadline.
JMAFF (Chair of Biologicals Quality Monitoring EWG)
DMF Procedures and Communication between API, FFP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
Changes to Grandfathered Equipment Recent Developments from discussions with EASA and the FAA Mark Barker 2 nd March 2016.
Variations regulation – an Industry experience
An agency of the European Union Guidance on the Submission of Clinical Reports intended for Publication in Accordance with Policy 0070 Principles Industry.
Ensuring quality of medicines procured with Global Fund resources HIV AIDS conference Satellite on Essential Medicines for HIV AIDS Mexico 6 August 2008.
Part Approval / Compliance Data Submission via Jotform.com
POST APPROVAL CHANGE MANAGEMENT PROTOCOLS IN THE EUROPEAN UNION
Paediatric Medicine: The Paediatric Investigation Plan
process and procedures for assessments
Post-Notice of Compliance (NOC) Changes
CHANGE CONTROL.
Administration of a FIDIC Contract - Project Control
Fair Go Rates System Dr Ron Ben-David Chairperson
Content of Tender Dossier - Instructions to Tenderers - Tenders
Content of Tender Dossier Instructions to Tenderers
4.4 Procurement by grant beneficiaries
International Open Procedure (1) – PRAG 4.3
Online Training Course
Part Approval / Compliance Data Submission via Jotform.com
Engineering Waiver Management
To the ETS – PNG Continuation: Online Training Course
Fair Go Rates System Dr Ron Ben-David Chairperson
Operationalizing Export Certification and Regionalization Programmes
I want to submit a grant. What do I do?
The WHO Prequalification of Medicines Programme Dossier Assessment
This presentation document has been prepared by Vault Intelligence Limited (“Vault") and is intended for off line demonstration, presentation and educational.
The European Pharmacopoeia and Pharmeuropa
Presentation transcript:

Revisions of Certificates of Suitability (CEP) to the Monographs of the European Pharmacopoeia Dr Pascale POUKENS-RENWART Scientific Officer Certification of Substances Division EDQM P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Validity of CEP Once your CEP has been granted it must be maintained throughout its lifetime! P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Basic principles for maintaining a CEP Any change (administrative or technical) must be reported to EDQM for approval Original CEP: valid 5 years. Holder needs to apply for renewal in time (6 months before expiry) After renewal, CEP valid for an unlimited period, provided the dossier is kept up-to-date In all cases, holder to inform customers of the change Revised CEP to be sent to customers P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

How EDQM handles variations ? P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Revisions of CEPs: Background Based on EU Regulations on Variations to Marketing Applications Specific guidelines for revisions of CEPs: Guideline on requirements on revision / renewal of CEPs (PA/PH/CEP (04) 2 3R)* New procedures for management of revision / renewal of CEPs (PA/PH/Exp. CEP/T (04) 18 1R)* *available on EDQM website P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Revisions of CEPs: Background Review and changes implemented on July 2008 -> Previously, CEP was revised after each request for revision (even if content was not affected) -> Now : for minor revisions except change of specification of the final substance, the CEP is NOT revised anymore but a notification of approval is sent instead. P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Types of changes Notifications Minor changes Major changes Renewal (after 5 years) Update following revision of the monograph / regulatory change Fee and deadlines available on EDQM website P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Application for a revision Application form (specific for revisions/available on website) Technical data (as detailed in Guideline on requirements on revision / renewal of CEPs (PA/PH/CEP (04) 2)) : Justification of change Assurance that the conditions are fulfilled Updated pages of the dossier Specific supporting documents COMPARATIVE DATA - Full batch results P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Notification Simple 2 weeks/500 euros Timescales and Fees Simple 2 weeks/500 euros Multiple (max. 3) 30 days/1000 euros Workflow: No Acknowledgement of Receipt Letter sent to advise that either the notification has been accepted as valid or has been rejected - No request for additional information Revised CEP only issued when the information on the CEP is changed (i.e. and address) P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Typical notifications Change in holder, manufacturer references: holder name, address (no move),... Deletion of information from CEP: manufacturing site, retest period, country of origin for TSE,.. Change in batch size by < x 10 P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Typical notifications Minor changes to test procedures (no changes in performances - few cases in practice) Tightening limits (methods not affected) Post-stability commitment data. P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Minor Change Single 30 days/1000 euros Timescales and Fees Single 30 days/1000 euros Multiple (max. 3) 60 days/1500 euros Workflow: Acknowledgement of Receipt sent within 5 days One request for additional information sent if necessary Holder has 30 days to respond to this request EDQM has 30 days to evaluate the response Notice of approval, revised CEP issued or request for revision rejected P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Typical minor changes Minor change in manufacture Upscaling > x10 Change in specification of the final substance (new or replaced test parameter) Change in specification of raw materials P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Typical minor changes Change/Addition of manufacturing site (! Route of synthesis should be identical Change of supplier of starting material (! Route of synthesis should be identical) Change from a TSE risk to a non-TSE risk material Change/Addition of retest period on CEP P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Major Change 90 days/1500 euros Timescales and Fees 90 days/1500 euros Possibility to include several changes (1major, up to 3 in total) Workflow: Acknowledgement of Receipt sent within 5 days One request for additional information sent if necessary Holder has 30 days to answer this request EDQM has 30 days to evaluate the response Revised CEP issued or request for revision rejected P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Typical major changes Any changes not included in the guideline (or where conditions not fulfilled) Examples (chemical): Introduction of new reagents, solvents Alternative process (-> Specification of the final substance should remain identical, otherwise NEW certificate) Process replaced Change of supplier of starting material with a different route of synthesis Examples (TSE): Addition of new source countries or suppliers of materials P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Consolidated Revision Timescales and Fees: Multiple revisions (> 3) 120 days/2500 euros - can include major changes Workflow: Acknowledgement of Receipt sent within 5 days One request for additional information sent if necessary Holder has 30 days to respond to this request EDQM has 30 days to evaluate the response Approval, revised CEP issued or request for revision rejected P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Monograph Revision Workflow: Job initiated by EDQM: when a revised monograph is published, EDQM sends request for data (either demonstration of compliance or suitability of the monograph) Holder asked to supply the requested information within 3 months P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Monograph Revision (cont) Workflow (cont): Response assessed within 3 months Approval or revised CEP issued (if the information on the CEP changes) P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Renewal  Renewed CEP issued prior to expiry date Holder to apply about 6 months before expiry Possibility to include changes in the request (no major changes): an updated dossier (CTD) with a comprehensive list of changes and supportive data must be submitted If declaration that no change has occurred since the last revision : dossier is assessed with priority  Renewed CEP issued prior to expiry date P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Renewal (cont) Timescales and Fees Workflow: 4 months/1500 euros Acknowledgement of Receipt sent within 5 days 4 months to evaluate the request Revised CEP issued, request for additional information sent If Demand for additional information sent Holder has 30 days to respond to this demand EDQM has 30 days to evaluate the response If holder applied in time and evaluation on-going: the CEP will be temporarily renewed at expiry unless there is an unresolved issue with the dossier P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Renewal (cont) Assessment of the dossier covers: Compliance with General Monograph 2034 “Substances for Pharmaceutical Use” Compliance with recent European quality guidelines: e.g. impurities, residual solvents, residual catalysts Any declared changes Not an administrative job! P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Some clarifications Change in the analytical method: N7 or R3 Replacement of a solvent: Major Change of strain in fermentation process: Major Alternative process: if the specifications are changed : New application to be submitted P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Some clarifications (cont) New supplier of starting material/intermediate with a declaration that the route of synthesis of the concerned materials is exactly the same as that already approved: Minor !Any invalid declaration, will be rejected at any time New supplier of starting material /intermediate when route of synthesis is not identical: Major P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Some clarifications (cont) Any change not listed in the descriptions for notifications or minor change is generally considered a major change. Possibility to contact EDQM for clarification (via Helpdesk) P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Some clarifications (cont) Replacement of acetonitrile in the route of synthesis / analytical methods due to global shortage : Such changes will require the submission of variation applications together with appropriate supporting data. Any resulting revision will be assessed as a fast-track procedure (within 1 month of receipt), provided no other changes are included in the request for revision. P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

What to do after approval of a request for revision ? Quid for MAA ? What to do with a revised CEP ? RX-CEP 2009-001-Rev YY Provide a copy to customers Update of relevant Marketing Applications Type IA variation in most cases (cf. European regulation Variation)  Mandatory P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

After approval What to do when change is approved but CEP not revised?: Inform customers to allow them to check potential impact on the finished medicinal product  Mandatory P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

When are CEPs revised ? After minor revisions related to change of specification of the final substance (since July 2008), even if the content remains unchanged. After any major revisions After any notification/minor revisions impacting the content of CEP When conclusion of assessment of renewal invalids the temporarily renewed CEP at expiry P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Coming soon… Revised Regulation on Variations to marketing applications adopted, implementation on 01/01/2010 Related guidelines on operations and classification under public consultation, adoption foreseen before end 2009 Impact on management of revisions of CEPs  EDQM guidelines will also be revised accordingly Some changes in the classification Some operational changes as well P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

Support to applicants Before preparing a request for revision Check EDQM website for: Published Guidelines & Notes (pages “Revisions & Renewals) FAQs contact EDQM for clarification (Helpdesk) Read How to prepare a good revision/renewal dossier (PA/PH/Exp. CEP/T (07) 49) Use Technical advice in case of doubt / complex schemes / specific questions: P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved

 Thank you ! P. Poukens Renwart, 05/09/09 ©2009 EDQM, Council of Europe, All rights reserved